Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.

Annals of internal medicine - 1 Jun 2023

Holbrook Anne M

Abstract excerpt

SOURCE CITATION: Swen JJ, van der Wouden CH, Manson LE, et al; Ubiquitous Pharmacogenetics Consortium. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401:347-356. 36739136.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Related Side Effects and Adverse Reactions
Share to Genotype
Share to Multicenter Studies as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 37276599
DOI: 10.7326/J23-0031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.PMID 37276599Read ↗

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.Semantic proximity Read ↗

What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?Semantic proximity Read ↗

Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community-Dwelling Older Adults.Semantic proximity Read ↗

Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.Semantic proximity Read ↗

Evaluating genotype-treatment interactions for high-risk medications in British general practice: a retrospective cohort study using UK Biobank.Semantic proximity Read ↗

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.Semantic proximity Read ↗

Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.Semantic proximity Read ↗

Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis.Semantic proximity Read ↗

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribingSemantic proximity Read ↗

Potential Role of Pharmacogenomics in Reducing Adverse Drug ReactionsSemantic proximity Read ↗

How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing.Semantic proximity Read ↗

The Global Compatibility Index (GCI): A Variance-Weighted Pharmacogenomic Scoring System Demonstrates Near-Perfect Cross-Mode Consistency (ICC = 0.994) and Improves Warfarin Dose Prediction Over the CPIC Algorithm in 5,475 Patients Across Four Continents, with Multi-Drug Validation Across 10 Independent DatasetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.